The Theranostics Trial Center (TTC) at Karolinska University Hospital has been awarded financing from Vinnova to run a new project in precision medicine.
By combining image-guided diagnostics and therapy with radioactively labeled target-seeking drugs, the project aims to revolutionize cancer treatment in Sweden.
“This grant is a big step for our research and a clear signal that Sweden is investing in becoming a leading nation in the growing theranostics research,” says Professor Rimma Axelsson, scientific leader of the Theranostics Trial Center at Karolinska University Hospital. “Our goal is to realize the promise of precision medicine – to offer tailored diagnostics and treatment that can improve survival and quality of life for seriously ill patients.”
The “Precision Medicine of the Future” initiative
The Theranostics Trial Center (TTC) at Karolinska University Hospital and Karolinska Institutet has been awarded a large grant of over SEK 15 million from the innovation authority Vinnova, as part of the “Precision Medicine of the Future” initiative. TTC’s application “Theranostic Trial Alliance: Image-guided diagnostics and therapy with target-seeking radiopharmaceuticals” was one of the most innovative and promising among the 53 applications received, and is considered to have great potential to revolutionize Swedish healthcare.
The purpose of the project is to create a strong innovation environment where precision medicine and pioneering treatments with radioactively labeled target-seeking drugs can be developed and implemented in clinical practice. The newly formed Theranostic Trial Alliance (TTA) Sweden is a collaborative project between Swedish hospitals, researchers, academia, pharmaceutical companies and the Life Science sector. Through this partnership, TTA wants to speed up the transfer of the latest research advances in theranostics, a field that combines diagnostics and treatment in the same process to better target efforts against specific cancers.
Photo of Thuy Tran Group, Rimma Axelsson, Renske Altena, Thuy Tran, Fredrik Frejd, and Peter Lindgren: Stefan Zimmerman/Karolinska Institutet
